4//SEC Filing
Rubin Jonathan 4
Accession 0001628280-25-003016
CIK 0001356576other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:01 PM ET
Size
6.4 KB
Accession
0001628280-25-003016
Insider Transaction Report
Form 4
Rubin Jonathan
SVP, Chief Medical Officer
Transactions
- Award
Performance Share Units
2025-01-28+1,875→ 1,875 totalExercise: $0.00→ Common Stock (1,875 underlying)
Holdings
- 6,905
Common Stock
Footnotes (2)
- [F1]Includes an aggregate of 310 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
- [F2]On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001836067
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 5:01 PM ET
- Size
- 6.4 KB